Related Experiment Videos

Acquisition, spread, and control of Pseudomonas aeruginosa in a cardiothoracic intensive care unit

Thorax
|October 1, 1982
PubMed

Insights

Pseudomonas aeruginosa acquisition in cardiothoracic ICUs is low, primarily affecting long-stay patients. Key risk factors include broad-spectrum antibiotics and tracheostomy, suggesting targeted infection control strategies.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Pseudomonas aeruginosa is a significant nosocomial pathogen, particularly in intensive care units.
  • Understanding acquisition patterns is crucial for effective infection control in vulnerable patient populations.
  • Cardiothoracic intensive care units (ICUs) present unique challenges for managing infections due to patient acuity.

Purpose of the Study:

  • To investigate the isolation rate and spread of Pseudomonas aeruginosa in a cardiothoracic ICU over 2.5 years.
  • To identify patient groups and risk factors associated with Pseudomonas aeruginosa acquisition.
  • To evaluate the impact of isolation measures on infection control.

Main Methods:

  • Prospective study over two and a half years in a cardiothoracic intensive care unit.
  • Monitoring of Pseudomonas aeruginosa isolation rates and patient demographics.
  • Analysis of patient care factors, including duration of ICU stay, antibiotic use, and tracheostomy.

Main Results:

  • Overall acquisition rate of Pseudomonas aeruginosa was low at 2.68%.
  • Acquisition was concentrated in patients requiring prolonged intensive care (over seven days).
  • Broad-spectrum antibiotic use and tracheostomy were significantly associated with Pseudomonas aeruginosa acquisition in long-stay patients.
  • Improved isolation facilities correlated with the confinement of acquisition to the long-stay patient group.

Conclusions:

  • Pseudomonas aeruginosa acquisition in cardiothoracic ICUs can be effectively controlled with adequate isolation measures.
  • Long-stay patients, particularly those on broad-spectrum antibiotics or with tracheostomies, are at highest risk.
  • Narrow-spectrum chemoprophylaxis for open-heart surgery may be a relevant infection control strategy.

Related Concept Videos